Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil
Status:
Completed
Trial end date:
2018-06-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
- To assess the effect of BIA 5 1058 400 mg on the pharmacokinetics (PK) of sildenafil.
- To assess the effect of sildenafil on the PK of BIA 5-1058.